Stockreport

Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025 [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The companies that make those drugs predict. The weight loss drug frenzy took off when the FDA approved Novo Nordisk A/S's (NYSE: NVO ) Wegvoy (semaglutide) in 2021. E [Read more]